Bulletin
Investor Alert

Indaptus Therapeutics Inc.

NAS: INDP

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Indaptus Therapeutics Inc.

After Hours

 --Quotes are delayed by 20 min

Mar 28, 2023, 5:00 p.m.

INDP
/zigman2/quotes/204811863/composite

$

1.95

Change

+0.19 +10.80%

Volume

Volume 20

Quotes are delayed by 20 min

/zigman2/quotes/204811863/composite

Today's close

$ 1.82

$ 1.76

Change

-0.06 -3.03%

Day low

Day high

$1.75

$1.81

Open

52 week low

52 week high

$1.25

$4.25

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Indaptus Therapeutics Inc.

View Ratios
Fiscal year is February-January. All values USD millions. 20212020201920182017 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A 1,403852854,000859,000829,000
COGS excluding D&A -----
Depreciation & Amortization Expense -852--829,000
Depreciation -852--829,000
Amortization of Intangibles -----
Gross Income (1,403)(852)(854,000)(859,000)(829,000)
20212020201920182017 5-year trend
SG&A Expense 7.73M3.6M34.09M42.47M28.61M
Research & Development -2.66M--24.3M
Other SG&A 5.2M943,3967.43M7.07M4.32M
Other Operating Expense -----
Unusual Expense --13.65M194,000(220,000)
EBIT after Unusual Expense --(48.6M)(43.52M)220,000
Non Operating Income/Expense -15,110--70,000
Non-Operating Interest Income ----286,000
Equity in Affiliates (Pretax) -----
Interest Expense --15,00023,00017,000
Gross Interest Expense ----17,000
Interest Capitalized -----
Pretax Income (7.71M)(3.58M)(46.96M)(43.44M)(28.88M)
Income Tax --638,000103,00029,000
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (7.71M)(3.58M)(47.6M)(43.54M)(28.91M)
Minority Interest Expense -----
Net Income (7.71M)(3.58M)(47.6M)(43.54M)(28.91M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (7.71M)(3.58M)(47.6M)(43.54M)(28.91M)
Preferred Dividends -----
Net Income Available to Common (7.71M)(3.58M)(47.6M)(43.54M)(28.91M)
EPS (Basic) (1.89)(7.37)(112.74)(111.67)(130.96)
Basic Shares Outstanding 4.09M486,168422,200389,913220,750
EPS (Diluted) (1.89)(7.37)(112.74)(111.67)(130.96)
Diluted Shares Outstanding 4.09M486,168422,200389,913220,750
EBITDA (7.73M)(3.6M)(34.09M)(42.47M)(28.61M)
Copyright 2023 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.